Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment

BACKGROUND: Evidence on whether the therapeutic effect and good safety profile of onabotulinumtoxinA (Botox®) in chronic migraine (CM) patients is maintained over long term treatment is still limited. We herein aimed at assessing whether there is a sustained benefit and good safety with repeated ona...

Descripción completa

Detalles Bibliográficos
Autores principales: Vikelis, Michail, Argyriou, Andreas A., Dermitzakis, Emmanouil V., Spingos, Konstantinos C., Makris, Nikolaos, Kararizou, Evangelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755578/
https://www.ncbi.nlm.nih.gov/pubmed/30225735
http://dx.doi.org/10.1186/s10194-018-0918-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755578/
https://www.ncbi.nlm.nih.gov/pubmed/30225735
http://dx.doi.org/10.1186/s10194-018-0918-3

Ejemplares similares